4 Analysts. 4 Buy Ratings: Huge Potential Revaluation Ahead For This Biotech

This biotech is targeting a billion-dollar heart market. Analyst upside targets are in triple digit percentage gains.

BTAI
BioXcel Therapeutics Inc
NASDAQ
3.6
Open 3.48 Prev Close 3.62
High 3.72 Low 3.48
Volume 1,691,335 Volume (Avg) 9,295
52 Week High 13.36 52 Week Low 1.17
Market Cap 52.3M PE Ratio

About BioXcel Therapeutics Inc

BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It also develops its neuroscience candidate, BXCL501, which is an investigational, proprietary, orally dissolving film formulation of dexmedetomidine in Phase 3 trial for the treatment of agitation associated with bipolar disorders, schizophrenia, and Alzheimer's disease, as well as opioid use disorder, alcohol use disorder with comorbid post-traumatic stress disorder, and acute stress disorder; and its immune-oncology candidate, BXCL701, which is an investigational oral innate immune activator that has completed Phase 1b/2a trial for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors. In addition, the company engages in the development of BXCL502 for the treatment of stress-related neuropsychiatric symptoms in dementia and other stress-related disorders; BXCL503, a drug candidate to target apathy in dementia; and BXCL504, which has the potential to address apathy and aggression in dementia. The company has collaborations with Columbia University, Yale University Medical School, and University of North Carolina for the development of BXCL501. BioXcel Therapeutics, Inc. was incorporated in 2017 and is headquartered in New Haven, Connecticut.

General

NameBioXcel Therapeutics Inc
TickerBTAI
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees37

Highlights

Analyst Target19.40
Market Cap52,300,000
EBITDA-49,847,000

Share Stats

Shares Outstanding14,560,000
Shares Float13,210,000
Shares Short1,520,000
Insider Holdings378%
Institution Holdings6.19%

Highlights

Analyst Target19.40
Market Cap52,300,000
EBITDA-49,847,000

Valuation

Price/Sales (Trailing 12 Mt.)60.71
Price/Book (Most Recent Quarter)3.97

Earnings

Most Popular

Google facing $425.7 million in damages for nearly a decade of improper smartphone snooping

SAN FRANCISCO (AP) — A federal jury has ordered Google to pay $425.7 million for improperly snooping on people's smartphones during a nearly decade-long period of intrusions.

LSD shows promise for reducing anxiety in drugmaker's midstage study

WASHINGTON (AP) — reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a that has been banned in the U.S. for more than a half century.

How to Hack a $1.3 Trillion Industry - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Led by former Zillow execs, their tech hacks a $1.3T market by letting buyers co-own homes worldwide. They've already earned $110M in gross profits and reserved the Nasdaq ticker PCSO.

AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim

AT&T customers, both present and past, stand to receive up to $7,500 as part of a proposed $177 million settlement. This settlement is in response to two significant data breaches that affected millions of AT&T customers.

IRS Reportedly Confirms $1,390 Stimulus Checks For Eligible Americans, Rumors of $2,000 August Payout Debunked — Plans Late Summer Rollout (UPDATED)

Millions of Americans may be eligible for a $1,390 stimulus check by the U.S. Department of the Treasury and the Internal Revenue Service, as part of a plan aiming to provide financial relief to low and middle-income households.

Keep This Stock on Your Watchlist - Ad

They're a private company, but the same firms that backed Uber, eBay, and Venmo already invested in Pacaso. They've even reserved their Nasdaq stock ticker.

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

How To Earn $500 A Month From Walmart Stock Ahead Of Q2 Earnings

Walmart offers a quarterly dividend amount of 23 cents per share. To earn $500 monthly, start with the yearly target of $6,000.

Mystery surrounds $1.2 billion Army contract to build huge detention tent camp in Texas desert

WASHINGTON (AP) — When last month awarded a contract worth up to $1.2 billion to build and operate what it says will become , it didn’t turn to a large government contractor or even a firm that specializes in private prisons.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Trump weaponization czar urged New York Attorney General James to resign over mortgage probe

NEW YORK (AP) — President Donald Trump’s political weaponization czar sent urging New York Attorney General Letitia James to resign from office “as an act of good faith” four days after starting his mortgage fraud investigation of her. Then he outside her house.

$9 Target on a $1.50 Biotech. Time to Look Closer - Ad

This biotech is targeting a billion-dollar heart market. Analyst upside targets are in triple digit percentage gains.

Jim Cramer Refuses To Chase Rally—Says 'We Sure Aren't Buying' Unless It's Discounted

Jim Cramer is sitting out the current market rally, citing excessive intervention, overbought conditions as key reasons to remain cautious.

Wall Street Sees 600% Potential Upside. Do You? - Ad

This biotech is targeting a billion-dollar heart market. Analyst upside targets are in triple digit percentage gains.

780,000 pressure washers are under recall after some consumers report explosions and impact injuries

NEW YORK (AP) — About 780,000 pressure washers sold at retailers like Home Depot are being recalled across the U.S. and Canada, due to a projectile hazard that has resulted in fractures and other injuries among some consumers.

$9 Analyst Target on a $1.50 Company. Big Breakout Could Be Coming - Ad

This biotech is targeting a billion-dollar heart market. Analyst upside targets are in triple digit percentage gains.

XRP Slips Below $3 But It Will Outperform ETH From Here, Trader Touts

XRP (CRYPTO: XRP) is expected to outperform Ethereum (CRYPTO: ETH) in the upcoming months, according to market commentators bullish on the token’s futur

Trump Tariffs Likely To Be Struck Down As 'Unconstitutional' In Appellate Court, Says Peter Schiff: Handing The President 'Another Scapegoat'

Economist Peter Schiff says that President Donald Trump's tariffs are likely headed for defeat at the U.S. Appellate Court, setting the stage for what he refers to as "another scapegoat" for the coming recession.

October 16 Changes the Microchip Game - and Investing - Ad

George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar.

Wall Street May Be Overlooking Dangers Of Trump's Ongoing Fed Assault, Warn Economists: 'Financial Markets Might Not…'

In a recent survey, economists have cautioned that the financial markets are not fully considering the potential risks of President Donald Trump's ongoing assaults on the Federal Reserve.

Salmonella outbreak tied to recalled eggs has sickened 95 people since January

At least 95 people in more than a dozen states have been sickened since January in an outbreak of salmonella poisoning tied to recalled eggs, federal health officials

Why This AI Play Could Shock Wall Street - Ad

Chatbots minted billion-dollar valuations. But the next wave of AI Agents could be bigger. One small-cap is already profitable with 88% margins, $3B processed, and Q3 2025 as its trigger.

Asian shares are mixed in quiet trading as traders await cues from the Fed

BANGKOK (AP) — Shares were mixed in Asia on Tuesday after Wall Street held near its records, with traders awaiting fresh cues about interest rates from the U.S. Federal Reserve.

New Jersey's massive American Dream mall sued for selling clothes on a Sunday

On any given Sunday, in New Jersey allows visitors to hit an indoor ski slope, surf an artificial wave, ride roller coasters — or shop for a new outfit at dozens of big-name retail stores.

4 Analysts. 4 Buy Ratings: Huge Potential Revaluation Ahead For This Biotech - Ad

This biotech is targeting a billion-dollar heart market. Analyst upside targets are in triple digit percentage gains.

Trump Ends De-Minimis Exemptions To All Countries: How This Will Impact Your Online Shopping

President Donald Trump's executive order, which ends de minimis exemptions, is set to take effect on Friday. This will effectively close the duty-free shipping loophole that allowed small commercial packages worth $800 or less to enter the United States without being subject to taxes or tariffs.

Podcasters and influencers: The unexpected jobs covered under Trump's 'no tax on tips' plan

WASHINGTON (AP) — Golf caddies, blackjack dealers and house painters are among the jobs covered under the preliminary list of occupations no required to pay income tax on their tips under Republicans' new tax cuts and spending bill.

How to Hack a $1.3 Trillion Industry - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Led by former Zillow execs, their tech hacks a $1.3T market by letting buyers co-own homes worldwide. They've already earned $110M in gross profits and reserved the Nasdaq ticker PCSO.

Keep This Stock on Your Watchlist - Ad

They're a private company, but the same firms that backed Uber, eBay, and Venmo already invested in Pacaso. They've even reserved their Nasdaq stock ticker.

What's Going On With Palantir Technologies Stock?

Shares of Palantir are trading lower Wednesday afternoon. The stock is continuing a recent pullback from all-time highs.

Cathie Wood's Thursday Bet: ARK Just Bought $31 Million Worth Of Falling Deere Stock, Also Loads Up On Block, Robinhood Shares

Ark Invest, led by Cathie Wood, made significant trades on Thursday — focusing on Deere & Co. (NYSE:DE), Block Inc. (NYSE:XYZ) and Robinhood Markets Inc. (NASDAQ:

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

Tariff Impact Exposes Aluminum Market Fragility

US and EU face challenges in aluminum supply chain due to Trump's tariff policy. EU prepares emergency measures to protect industry.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service